Company Filing History:
Years Active: 2022
Title: Javelin Chi: Innovator in Genetic Detection
Introduction
Javelin Chi is a notable inventor based in Pleasanton, CA (US). He has made significant contributions to the field of genetic detection, particularly through his innovative patent. His work focuses on enhancing the sensitivity and specificity of gene fusion detection, which is crucial for actionable medical insights.
Latest Patents
Javelin Chi holds a patent for "Multiplex PCR detection of ALK, RET, and ROS fusions." This patent provides methods and compositions for multiplex detection of a large number of actionable gene fusions with very high sensitivity and specificity. The present methods can detect ALK, RET, and ROS1 gene fusions, optionally in combination with other mutations and fusions. This advancement is vital for improving diagnostic capabilities in molecular biology.
Career Highlights
Throughout his career, Javelin Chi has worked with prominent companies in the biotechnology sector. He has been associated with Roche Molecular Systems, Inc. and Roche Diagnostics GmbH, where he contributed to various projects aimed at enhancing genetic testing technologies. His expertise in the field has positioned him as a valuable asset in the industry.
Collaborations
Javelin has collaborated with several professionals in his field, including Ann Begovich and Cindy Cheung. These collaborations have further enriched his work and contributed to advancements in genetic detection methodologies.
Conclusion
Javelin Chi's innovative work in multiplex PCR detection has made a significant impact on the field of genetic diagnostics. His contributions continue to pave the way for advancements in medical technology and patient care.